Kelonia Therapeutics logo

Kelonia Therapeutics jobs and careers

Cambridge, England, United Kingdom

About Kelonia Therapeutics

Kelona is revolutionizing gene delivery to expand the impact of genetic medicines. Their goal is to develop a new wave of accessible genetic medicines that will transform the lives of patients suffering from a broad range of conditions.

Founded in 2017 by Kevin Friedman, Michael Birnbaum, Michael Fischbach and Molly Perkins.

Founded
2017
Employees
11 to 50
Total funding
$50M
Headquarters
Cambridge

Leadership

The top of Kelonia Therapeutics's org chart, with how many people report into each leader.

KFPhoto of Kevin Friedman

Kevin Friedman

Chief Executive Officer

43 reports

LSPhoto of Laura Sandler

Laura Sandler

SVP, Strategic Operations

17 reports

STPhoto of Sarah Tannehill-Gregg

Sarah Tannehill-Gregg

Vice President, Preclinical Development

10 reports

MQPhoto of M. Travis Quigley

M. Travis Quigley

SVP. Clinical Development, Technical Development Operations, and Program and Alliance Management

9 reports

MMPhoto of Michael McDonald

Michael McDonald

Senior Vice President, Head of Intellectual Property and Legal Affairs

1 report

JR

James Rottman

Senior Vice President and Head of Research

1 report

CSPhoto of Charlene Stern

Charlene Stern

Chief Business Officer

Board

BMPhoto of Bob More

Bob More

Board Member

BRPhoto of Bryan Roberts

Bryan Roberts

Board Member

MBPhoto of Michael Birnbaum

Michael Birnbaum

Board Member

Jobs at Kelonia Therapeutics

No open positions right now. Explore more companies on TheJobsMap.